Bharat Biotech

Showing of 1 - 20 from 29 results
Bharat Biotech - Total results - 29
Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials
India

Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials

The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above.

Roll-out of Feluda test for detecting COVID-19 expected in next few weeks, says Harsh Vardhan
India

Roll-out of Feluda test for detecting COVID-19 expected in next few weeks, says Harsh Vardhan

In the fifth episode of 'Sunday Samvaad', the health minister also said the decision on emergency use authorisation for vaccines against the virus will depend on results of the clinical trials

CDSCO asks Bharat Biotech to submit complete immunogenicity data of Phase 2 trial of COVID-19 vaccine
India

CDSCO asks Bharat Biotech to submit complete immunogenicity data of Phase 2 trial of COVID-19 vaccine

The vaccine candidate, 'Covaxin', is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research

India's COVID-19 count crosses 56 lakh as 83,347 more test positive; Union minister Suresh Angadi dies of infection
India

India's COVID-19 count crosses 56 lakh as 83,347 more test positive; Union minister Suresh Angadi dies of infection

India's coronavirus case count on Wednesday surged to 56,46,010 with 83,347 more testing positive since 8 am on Tuesday while the toll climbed to 90,020 with 1,085 more fatalities, according to the Union health ministry

Bharat Biotech to begin Phase-3 humans trials of COVAXIN candidate from 15 Oct in Punjab
India

Bharat Biotech to begin Phase-3 humans trials of COVAXIN candidate from 15 Oct in Punjab

Punjab CM Amarinder Singh gave stern directives about the poor not being pulled into trials without consent and understanding of the potential dangers.

Bharat Bio's COVAXIN: Ten takeaways from successful animal trials of the experimental COVID-19 vaccine
science

Bharat Bio's COVAXIN: Ten takeaways from successful animal trials of the experimental COVID-19 vaccine

The animal trials demonstrate that COVAXIN protected against SARS-CoV-2, and amped up two kinds of antibodies needed for a strong immune response against the virus.

India records 83,809 new cases, COVID-19 tally crosses 49 lakh; 5 states account for 60% of active cases, says health ministry
India

India records 83,809 new cases, COVID-19 tally crosses 49 lakh; 5 states account for 60% of active cases, says health ministry

India's COVID-19 caseload rose to 49,30,236 while the toll climbed to 80,776 with 1,054 people succumbing to the disease in 24 hours, the health ministry's data showed.

Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan
India

Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan

Two homegrown vaccine candidates — Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila — have almost finished the phase II clinical trials

Emerging landscape of COVID-19 vaccines in India, 14 Aug: Bharat Bio, Zydus move to Phase 2; Biological E, Bayor College tie up for COVID-19 vaccine
India

Emerging landscape of COVID-19 vaccines in India, 14 Aug: Bharat Bio, Zydus move to Phase 2; Biological E, Bayor College tie up for COVID-19 vaccine

Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.

India readies five sites for final phase of human trials of Oxford's COVID-19 vaccine
science

India readies five sites for final phase of human trials of Oxford's COVID-19 vaccine

Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine

COVAXIN Phase 1 human trials begin; first dose administered to 30-year-old Delhi resident
India

COVAXIN Phase 1 human trials begin; first dose administered to 30-year-old Delhi resident

Over 3,500 volunteers have registered themselves for the trial at AIIMS this week, of whom the screening of 22 people is underway, doctors said

AIIMS panel gives nod to begin human clinical trial of COVID-19 vaccine Covaxin from 20 July
India

AIIMS panel gives nod to begin human clinical trial of COVID-19 vaccine Covaxin from 20 July

Covaxin, Bharat Biotech's COVID-19 vaccine candidate, has been developed in collaboration with the ICMR and NIV

Race for COVID-19 vaccine: Covaxin and ZyCoV-D begin human trials in India, Moderna publishes preliminary data from phase 1
Health

Race for COVID-19 vaccine: Covaxin and ZyCoV-D begin human trials in India, Moderna publishes preliminary data from phase 1

While Covaxin is an inactivated whole-virion vaccine, ZyCoV-D is a DNA-plasmid based vaccine.

Indian pharma well-placed to develop, manufacture COVID-19 vaccine; but it must guard against rushing trials
India

Indian pharma well-placed to develop, manufacture COVID-19 vaccine; but it must guard against rushing trials

Some experts told Firstpost that the government is willing to fast-track regulation, which is a risk they are willing to take, after completing "due protocols to check the safety of the drug"

COVAXIN controversy: Doctors in trial sites chosen by ICMR say human trials can’t be fast forwarded, anticipate 6-month observation period
India

COVAXIN controversy: Doctors in trial sites chosen by ICMR say human trials can’t be fast forwarded, anticipate 6-month observation period

Hyderabad-based Bharat Biotech received approval from the Central Drugs Standard Control Organisation (CDSCO) to begin human trials of COVAXIN last week. The vaccine has been developed in collaboration with the ICMR and National Institute of Virology in Pune.

Human trials of Indian COVID-19 vaccine candidates mark ‘beginning of pandemic’s end’, writes Vigyan Parisar scientist
India

Human trials of Indian COVID-19 vaccine candidates mark ‘beginning of pandemic’s end’, writes Vigyan Parisar scientist

Aiming to launch a COVID-19 vaccine by 15 August, ICMR had written to select medical institutions to expedite clinical trials for the candidate COVAXIN

PIB uploads article claiming none of six Indian companies working on COVID-19 vaccine will have it ready before 2021, later removes mention of year
India

PIB uploads article claiming none of six Indian companies working on COVID-19 vaccine will have it ready before 2021, later removes mention of year

The statement deleted from the article on PIB contradicted the Indian Council of Medical Research's plan to launch a vaccine by 15 August this year.

Day after ICMR's clarification on coronavirus vaccine, IASc calls timeline 'unprecedented and unfeasible'
India

Day after ICMR's clarification on coronavirus vaccine, IASc calls timeline 'unprecedented and unfeasible'

A day after the ICMR announced that it aims to launch a COVID-19 vaccine by 15 August, it issued a clarification saying the process to expedite trials was in accordance with norms

Make haste, but slowly say experts as Bharat Biotech officials keep mum on ICMR's 15 Aug deadline
India

Make haste, but slowly say experts as Bharat Biotech officials keep mum on ICMR's 15 Aug deadline

While the ICMR has said it is important to expedite the clinical trials for a promising indigenous vaccine in the public interest and that all other vaccine candidates across the globe have been similarly fast-tracked, scientists in one voice have cautioned against being over-optimistic

Coronavirus Updates: Confirmed cases in Maharashtra cross two lakh with 7,074 new infections reported today; toll reaches 8,671
India

Coronavirus Updates: Confirmed cases in Maharashtra cross two lakh with 7,074 new infections reported today; toll reaches 8,671

Coronavirus Updates: According to a state health department bulletin, over 1.98 lakh patients have been discharged till date and the recovery rate stands at 54.02 percent